Immunicum AB: Invitation to Investor Event
May 24 2018 - 2:00AM
Press Release
24 May 2018
Immunicum AB: Invitation to Investor Event
Immunicum AB
(publ; IMMU.ST) announced today that the Company will host an
investor event in Kalmar on June 13 starting at 18:00 CEST. Carlos
de Sousa, CEO of Immunicum, will give the current corporate
presentation and he and other members of the Immunicum leadership
team will be available for a question and answer session.
Kalmar
Date: Wednesday, June 13, 2018
Time: 18:00 - 20:00 CEST
Location: Kalmar Slott, Kungsgatan 1, 392 33
Kalmar
To register to
attend the event, please send an email to events@immunicum.com
with your full name.
For more information, please contact:
Carlos de Sousa, CEO,
Immunicum
Telephone: +46 (0) 31 41 50 52
E-mail: info@immunicum.com
Michaela Gertz, CFO,
Immunicum
Telephone: +46 70 926 17 75
E-mail: ir@immunicum.com
Media Relations
Gretchen Schweitzer and Joanne
Tudorica
Trophic Communications
Telephone: +49 172 861 8540
E-mail: ir@immunicum.com
About Immunicum AB (publ) Immunicum is establishing a unique
immuno-oncology approach through the development of allogeneic,
off-the-shelf cell-based therapies. Our goal is to improve survival
outcomes and quality of life by priming the patient's own immune
system to fight cancer. The company's lead product ilixadencel,
consisting of pro-inflammatory allogeneic dendritic cells, has the
potential to become a backbone component of modern cancer
combination treatments in a variety of solid tumor indications.
Founded and based in Sweden, Immunicum is publicly traded on the
Nasdaq Stockholm. www.immunicum.com
|
20180524_Immunicum_Investor
Event_ENG_Final
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Immunicum AB via Globenewswire
Immunomedics (NASDAQ:IMMU)
Historical Stock Chart
From Apr 2024 to May 2024
Immunomedics (NASDAQ:IMMU)
Historical Stock Chart
From May 2023 to May 2024